Molecular Switch for Alternative Fat-Burning Pathway Identified in Mice
Similar Articles
New Study Reveals Dual Role of Fat-Burning Enzyme in Health and Disease
Fat Cell Enzyme Found to Have Dual Role in Energy Regulation and Obesity
Leucine Amino Acid Found to Enhance Mitochondrial Energy Production
Preclinical Study Shows Hybrid Molecule Strategy May Improve Obesity and Diabetes Treatment
Study Identifies Brain Cells That Drive Exercise Endurance Gains
Scientists have discovered the molecular trigger for a hidden energy-burning system in brown fat. The findings, published in Nature, reveal that the same enzyme involved in this calorie-burning process is also essential for building strong bones. This dual role could open new avenues for treating metabolic and bone disorders.
Facts First
- Researchers identified glycerol as the molecular switch that activates an alternative heat-producing pathway in brown fat.
- The switch is an enzyme called TNAP, which is also essential for the process of bone calcification and hardening.
- Mutations that reduce TNAP activity cause hypophosphatasia, a rare bone disorder characterized by soft bones and fractures.
- The discovery builds on prior work that led to an enzyme replacement therapy for hypophosphatasia patients.
- Dozens of possible drug candidates have been identified for future investigation based on this research.
What Happened
A research team led by Lawrence Kazak at McGill University's Rosalind and Morris Goodman Cancer Institute has identified the molecular trigger for a previously hidden energy-burning system in mice. The system, known as the futile creatine cycle, operates in brown fat, which burns calories to generate heat. The trigger is glycerol, a molecule released when the body breaks down stored fat in response to cold. Researchers discovered that glycerol binds to and activates an enzyme called TNAP (tissue-nonspecific alkaline phosphatase).
Why this Matters to You
This discovery links two critical bodily systems: metabolism and bone health. The TNAP enzyme is essential for both activating a calorie-burning pathway in fat and for the calcification process that builds strong bones. This means future treatments targeting this single molecular switch could potentially address two types of conditions. For individuals with metabolic disorders, it may lead to therapies that help the body burn more energy. For those affected by bone disorders like hypophosphatasia—which is more common in certain parts of Canada—this research could inform the development of new, more effective treatments.
What's Next
The research team has already identified dozens of possible drug candidates for future investigation. These candidates may be explored for their potential to modulate the TNAP enzyme, aiming to treat conditions related to both metabolism and bone mineralization. The findings could also refine existing treatments, such as the enzyme replacement therapy previously developed for hypophosphatasia.